Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia

Launched by INSTITUTE OF HEMATOLOGY & BLOOD DISEASES HOSPITAL, CHINA · Apr 9, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on understanding and improving the growth and health of children and teenagers with thalassemia, a blood disorder that requires regular blood transfusions. Researchers want to find out how these children are growing and developing, as many of them experience growth delays. The study aims to create special plans to help these young patients with their health, nutrition, and physical activity. This includes regular check-ups, educational support for families, personalized diet plans, and exercise recommendations to promote healthy growth.

To participate in this trial, eligible candidates are children and teenagers aged 18 and under who have been diagnosed with transfusion-dependent thalassemia. If they join, they can expect to receive support to monitor their health and growth over a year, along with guidance on nutrition and lifestyle. The goal is to see if these interventions help improve their growth and overall well-being. This research is important not only for the children involved but also for families and the broader community, as it addresses a significant health issue faced by many in China.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects diagnosed with transfusion-dependent thalassemia (TDT)
• • Male or female age ≤18 years
• • Subjects who are willing and able to provide written informed consent
• Exclusion Criteria:
• • Not applicable